- Home
- CLDI vs AEON Comparison
CLDI vs AEON Comparison
Compare CLDI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- AEON
- Stock Information
- Founded
- CLDI 2014
- AEON N/A
- Country
- CLDI United States
- AEON United States
- Employees
- CLDI N/A
- AEON N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- CLDI Health Care
- AEON Health Care
- Exchange
- CLDI Nasdaq
- AEON Nasdaq
- Market Cap
- CLDI 8.7M
- AEON 8.0M
- IPO Year
- CLDI N/A
- AEON N/A
- Fundamental
- Price
- CLDI $1.60
- AEON $0.94
- Analyst Decision
- CLDI
- AEON Strong Buy
- Analyst Count
- CLDI 0
- AEON 1
- Target Price
- CLDI N/A
- AEON $360.00
- AVG Volume (30 Days)
- CLDI 141.6K
- AEON 128.8K
- Earning Date
- CLDI 11-11-2025
- AEON 11-12-2025
- Dividend Yield
- CLDI N/A
- AEON N/A
- EPS Growth
- CLDI N/A
- AEON N/A
- EPS
- CLDI N/A
- AEON N/A
- Revenue
- CLDI N/A
- AEON N/A
- Revenue This Year
- CLDI N/A
- AEON N/A
- Revenue Next Year
- CLDI N/A
- AEON N/A
- P/E Ratio
- CLDI N/A
- AEON N/A
- Revenue Growth
- CLDI N/A
- AEON N/A
- 52 Week Low
- CLDI $1.41
- AEON $0.38
- 52 Week High
- CLDI $46.68
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- CLDI 43.90
- AEON 72.13
- Support Level
- CLDI $1.41
- AEON $0.78
- Resistance Level
- CLDI $1.68
- AEON $0.85
- Average True Range (ATR)
- CLDI 0.08
- AEON 0.05
- MACD
- CLDI 0.05
- AEON 0.01
- Stochastic Oscillator
- CLDI 66.74
- AEON 95.39
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.